Clinical trial
Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist Devices
NCT02547766 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist Devices
- Lead sponsor
- University of Utah
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- December 31, 2016
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.